超过 59% 的美国狗超重，这刺激了新的宠物减肥药的开发。 Over 59% of U.S. dogs are overweight, spurring the development of new pet weight-loss drugs.

在美国，超过 59% 的狗超重，这个问题也影响了 61% 的猫。 Over 59% of dogs in the U.S. are overweight, a problem also affecting 61% of cats. 公司正在开发宠物减肥药，类似于 Wegovy 和 Ozempic 等人类药物。 Companies are developing weight-loss drugs for pets, similar to human drugs like Wegovy and Ozempic. 虽然宠物主人愿意为动物的健康花钱，但这种药物可能很昂贵。 While pet owners are willing to spend on their animals' health, such drugs may be expensive. 由于副作用，早期 FDA 批准的狗饮食药物被移除。 An earlier FDA-approved dog diet drug was removed due to side effects. 鼓励宠物主人考虑将饮食和运动作为替代方案。 Pet owners are encouraged to consider diet and exercise as alternatives.